Literature DB >> 10470920

MR imaging of endometrial stromal sarcoma: correlation with pathologic findings.

T Koyama1, K Togashi, I Konishi, H Kobayashi, H Ueda, M L Kataoka, H Kobayashi, T Itoh, T Higuchi, S Fujii, J Konishi.   

Abstract

OBJECTIVE: This study describes MR imaging of eight patients with endometrial stromal sarcoma and correlates the imaging findings with histopathologic findings. To our knowledge, the radiologic findings of this entity have not been reported in the literature.
CONCLUSION: Endometrial stromal sarcoma typically presents with extensive myometrial involvement, which is either sharply demarcated or diffusely infiltrative. Bands of low signal intensity are observed within the areas of myometrial involvement on T2-weighted images. These bands correspond to the preserved bundles of myometrium on pathologic examination. Tumor extension along the vessels or ligaments is another characteristic of MR imaging of endometrial stromal sarcoma.

Entities:  

Mesh:

Year:  1999        PMID: 10470920     DOI: 10.2214/ajr.173.3.10470920

Source DB:  PubMed          Journal:  AJR Am J Roentgenol        ISSN: 0361-803X            Impact factor:   3.959


  28 in total

1.  The essence of the Japan Radiological Society/Japanese College of Radiology Imaging Guideline.

Authors:  Yasuyuki Yamashita; Sadayuki Murayama; Masahiro Okada; Yoshiyuki Watanabe; Masako Kataoka; Yasushi Kaji; Keiko Imamura; Yasuo Takehara; Hiromitsu Hayashi; Kazuko Ohno; Kazuo Awai; Toshinori Hirai; Kazuyuki Kojima; Shuji Sakai; Naofumi Matsunaga; Takamichi Murakami; Kengo Yoshimitsu; Toshifumi Gabata; Kenji Matsuzaki; Eriko Tohno; Yasuhiro Kawahara; Takeo Nakayama; Shuichi Monzawa; Satoru Takahashi
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

2.  Differentiation of the various lesions causing an abnormality of the endometrial cavity using MR imaging: emphasis on enhancement patterns on dynamic studies and late contrast-enhanced T1-weighted images.

Authors:  Byung Kwan Park; Bohyun Kim; Jong Min Park; Jeong Ah Ryu; Mi Sung Kim; Duk Soo Bae; Geung Hwan Ahn
Journal:  Eur Radiol       Date:  2006-02-23       Impact factor: 5.315

3.  Staging of endometrial cancer with MRI: guidelines of the European Society of Urogenital Imaging.

Authors:  K Kinkel; R Forstner; F M Danza; L Oleaga; T M Cunha; A Bergman; J O Barentsz; C Balleyguier; B Brkljacic; J A Spencer
Journal:  Eur Radiol       Date:  2009-02-05       Impact factor: 5.315

4.  Magnetic resonance imaging features of endometrial stromal sarcoma: a case description.

Authors:  Chen Chen; You-Qiang Hu; Xiao-Ming Zhang
Journal:  Quant Imaging Med Surg       Date:  2017-02

5.  Sonographic findings of uterine endometrial stromal sarcoma.

Authors:  Jeong-Ah Kim; Myung Sook Lee; Jong-Sun Choi
Journal:  Korean J Radiol       Date:  2006 Oct-Dec       Impact factor: 3.500

6.  Adenomyosis with extensive glandular proliferation simulating infiltrating malignancy on magnetic resonance imaging.

Authors:  Kaoru Funaki; Hidenobu Fukunishi; Tetsuo Maeda; Chiho Ohbayashi; Satoshi Yamaguchi
Journal:  Jpn J Radiol       Date:  2011-05-24       Impact factor: 2.374

Review 7.  Endometrial stromal sarcoma: An aggressive uterine malignancy.

Authors:  Chaitra P Adiga; Manju Gyanchandani; Lakshmikantha N Goolahally; Rishikesh M Itagi; Kiran V Kalenahalli
Journal:  J Radiol Case Rep       Date:  2016-09-30

8.  Endometrial stromal sarcoma.

Authors:  Geetha Puliyath; V Rajasekharan Nair; Swetha Singh
Journal:  Indian J Med Paediatr Oncol       Date:  2010-01

9.  The utility of diffusion-weighted MR imaging for differentiating uterine sarcomas from benign leiomyomas.

Authors:  Ken Tamai; Takashi Koyama; Tsuneo Saga; Nobuko Morisawa; Koji Fujimoto; Yoshiki Mikami; Kaori Togashi
Journal:  Eur Radiol       Date:  2007-10-10       Impact factor: 5.315

Review 10.  Role of diffusion-weighted imaging in the diagnosis of gynecological diseases.

Authors:  Tomohiro Namimoto; Kazuo Awai; Takeshi Nakaura; Yumi Yanaga; Toshinori Hirai; Yasuyuki Yamashita
Journal:  Eur Radiol       Date:  2008-10-07       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.